Avinger announces issuance of three new u.s. patents in march 2022

16 new u.s. and international patents issued over past year redwood city, ca / accesswire / march 30, 2022 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the issuance of three new u.s. patents in march 2022 and provided an update on the expansion of its intellectual property portfolio. the following three new u.s. patents expanding intellectual property protection for avinger's proprietary imaging platform and image-guided therapeutic devices were issued in march 2022: u.s. patent 11,284,839, optical coherence tomography for biological imaging, broadens coverage for avinger's proprietary oct imaging platform.
AVGR Ratings Summary
AVGR Quant Ranking